Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.

Omar FahmyNabil Abdulhafiz AlhakamyMohd G Khairul-AsriOsama Abdelhakim Aly Ahmed Usama Ahmed FahmyClaudia G FrestaGiuseppe Caruso

Published in: Journal of personalized medicine (2021)

Checkpoint inhibitors provide modest oncological advantages in metastatic castration-resistant prostate cancer. There are currently no good predictive indicators that indicate a greater response in some patients.

Keyphrases

prostate cancer
radical prostatectomy
dna damage
end stage renal disease
squamous cell carcinoma
small cell lung cancer
cell cycle
chronic kidney disease
rectal cancer
ejection fraction
newly diagnosed
prognostic factors
robot assisted
oxidative stress
minimally invasive
patient reported